Case report: Neuroacanthocytosis associated with novel variants in the

VPS13A VPS13A disease ektacytometry feeding dystonia neuroacanthocytosis

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2024
Historique:
received: 29 03 2024
accepted: 02 09 2024
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 17 10 2024
Statut: epublish

Résumé

The diseases historically known as neuroacanthocytosis (NA) conditions include Investigations included clinical assessments, neuroimaging studies, laboratory analyses, blood smears, ektacytometry, psychometric evaluation, and genetic analyses. Using ektacytometry, an osmoscan curve is obtained yielding a diffraction pattern as a measure of average erythrocyte deformability from circular at rest to elliptical at a high shear stress. The pattern allows the derivation of several parameters (mainly EI-max, O-min and O-Hyper points). Samples from two other patients with genetically proven The patient has impulsivity, chorea and disabling feeding dystonia refractory to treatment and 15% acanthocytes in peripheral blood. Genetic workup revealed compound heterozygous variants c.1732_1733del; p.(V578Ffs*9) and c.8282C > A, p.(S2761*) in Pathogenicity of the

Sections du résumé

Background and objectives UNASSIGNED
The diseases historically known as neuroacanthocytosis (NA) conditions include
Methods UNASSIGNED
Investigations included clinical assessments, neuroimaging studies, laboratory analyses, blood smears, ektacytometry, psychometric evaluation, and genetic analyses. Using ektacytometry, an osmoscan curve is obtained yielding a diffraction pattern as a measure of average erythrocyte deformability from circular at rest to elliptical at a high shear stress. The pattern allows the derivation of several parameters (mainly EI-max, O-min and O-Hyper points). Samples from two other patients with genetically proven
Case presentation UNASSIGNED
The patient has impulsivity, chorea and disabling feeding dystonia refractory to treatment and 15% acanthocytes in peripheral blood. Genetic workup revealed compound heterozygous variants c.1732_1733del; p.(V578Ffs*9) and c.8282C > A, p.(S2761*) in
Conclusion UNASSIGNED
Pathogenicity of the

Identifiants

pubmed: 39416949
doi: 10.3389/fnins.2024.1409366
pmc: PMC11480079
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

1409366

Informations de copyright

Copyright © 2024 Paucar, Wincent, Rubin, Peikert, Kyhle, Hertegård, Möller, Beshara and Svenningsson.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Martin Paucar (M)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.

Josephine Wincent (J)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

Charlotta Rubin (C)

Department of Clinical Nutrition, Karolinska University Hospital, Stockholm, Sweden.

Kevin Peikert (K)

Translational Neurodegeneration Section "Albrecht Kossel," Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany.
Center for Transdisciplinary Neurosciences Rostock, University Medical Center Rostock, Rostock, Germany.
United Neuroscience Campus Lund-Rostock, Rostock, Germany.

Josefin Kyhle (J)

Department of Speech and Language, Karolinska University Hospital, Stockholm, Sweden.

Stellan Hertegård (S)

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Department of Otolaryngology, Karolinska University Hospital, Stockholm, Sweden.

Riita Möller (R)

Department of Otolaryngology, Karolinska University Hospital, Stockholm, Sweden.
Department of Medical Biology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Soheir Beshara (S)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.

Per Svenningsson (P)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH